Stockholm, V7CIK 15998824 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
94 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Regeneron Pharmaceuticals | 61.4K | $47.39M | 4.4% | +25.3K | Added |
| 2 | Eli Lilly & Co | 42.2K | $45.37M | 4.2% | −11.2K | Reduced |
| 3 | Boston Scientific Corp | 431.2K | $41.12M | 3.8% | −6.8K | Reduced |
| 4 | Medtronic PLC |
| 296.0K |
| $28.43M |
| 2.7% |
| +91.0K |
| Added |
| 5 | Intuitive Surgical Inc | 48.0K | $27.19M | 2.5% | −500 | Reduced |
| 6 | Cooper Cos Inc | 327.5K | $26.84M | 2.5% | +90.5K | Added |
| 7 | Cvs Health Corp | 335.5K | $26.63M | 2.5% | +58.1K | Added |
| 8 | Abbvie Inc | 110.6K | $25.27M | 2.4% | −19.8K | Reduced |
| 9 | Glaukos Corp | 210.0K | $23.71M | 2.2% | −20.0K | Reduced |
| 10 | Danaher Corporation | 99.1K | $22.67M | 2.1% | −35.4K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio